Copy Link Print Information

Braxlosiran

Customer Review

Based on 1 Customer Validation

Braxlosiran, one of the components of the AOC Delpacibart braxlosiran (HY-177566), is composed of a siRNA targeting DUX4 (dual homologous box protein) and SMCC linker (HY-42360). Abnormal expression of the DUX4 protein leads to changes in gene expression in muscle cells, and these changes are associated with the loss of muscle function in facioscapulohumeral muscular dystrophy (FSHD).

For research use only. We do not sell to patients.

  • Purity: 95.45%
  • Molecular Weight:13729.26
  • Storage:

    -20°C, sealed storage, away from moisture

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Braxlosiran Chemical Structure
    Braxlosiran Chemical Structure
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
Top Publications Citing

Use of MCE Products
Keywords
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Braxlosiran Chemical Structure
    Braxlosiran Chemical Structure RNA (Cm-sp-Gm-sp-Am-Cm-Gm-Gm-(2′-deoxy-2′-fluoro)A-(2′-deoxy-2′-fluoro)G-(2′-deoxy-2′-fluoro)A-Cm-Um-Cm-Gm-Um-Um-Um-Gm-sp-Gm-sp-Am), 5′-[6-[[[4-[(3-mercapto-2,5-dioxo-1-pyrrolidinyl)methyl]cyclohexyl]carbonyl]amino]hexyl hydrogen phosphate], complex with RNA (Um-sp-(2′-deoxy-2′-fluoro)C-sp-Cm-Am-Am-(2′-deoxy-2′-fluoro)A-Cm-Gm-Am-Gm-Um-Cm-Um-(2′-deoxy-2′-fluoro)C-Cm-(2′-deoxy-2′-fluoro)G-Um-Cm-Gm-sp-Um-sp-Um)
    1/16
  • RNA (Cm-sp-Gm-sp-Am-Cm-Gm-Gm-(2′-deoxy-2′-fluoro)A-(2′-deoxy-2′-fluoro)G-(2′-deoxy-2′-fluoro)A-Cm-Um-Cm-Gm-Um-Um-Um-Gm-sp-Gm-sp-Am), 5′-[6-[[[4-[(3-mercapto-2,5-dioxo-1-pyrrolidinyl)methyl]cyclohexyl]carbonyl]amino]hexyl hydrogen phosphate], complex with RNA (Um-sp-(2′-deoxy-2′-fluoro)C-sp-Cm-Am-Am-(2′-deoxy-2′-fluoro)A-Cm-Gm-Am-Gm-Um-Cm-Um-(2′-deoxy-2′-fluoro)C-Cm-(2′-deoxy-2′-fluoro)G-Um-Cm-Gm-sp-Um-sp-Um)